Indaptus Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.06

-0.35 (-10.26%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,232.4% upside

Low Target $30.54

Average Target $40.77

High Target $54.50

Current Price $3.06

Current
$3.06

Target
$40.77

$30.54 $40.77 avg $54.50

Scenario Analysis

Bear Case

$30.54

898.0%

Low target

Base Case

$40.77

+1,232.4%

Avg target

Bull Case

$54.50

+1,681.0%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$13.44

-77.2% from high

52-Week Low

$0.92

+232.6% from low

Target vs 52W High

$40.77

+203.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%